DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Johnston SR, Kilburn LS, Ellis P. et al. SoFEA investigators.
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.

Lancet Oncol 2013;
14: 989-998

Download Bibliographical Data

Access:
Access:
Access: